European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma

Chimeric antigen receptor (CAR) T cells (CAR-T) have dramatically changed the treatment landscape of B-cell malignancies, providing a potential cure for relapsed/refractory patients. Long-term responses in patients with acute lymphoblastic leukemia and non Hodgkin lymphomas have encouraged further d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Benedetto, Wäsch, Ralph, Engelhardt, Monika, Gay, Francesca, Giaccone, Luisa, D’Agostino, Mattia, Rodríguez-Lobato, Luis-Gerardo, Danhof, Sophia, Gagelmann, Nico, Kröger, Nicolaus, Popat, Rakesh, van de Donk, Niels W C J, Terpos, Evangelos, Dimopoulos, Meletios A, Sonneveld, Pieter, Einsele, Hermann, Boccadoro, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327729/
https://www.ncbi.nlm.nih.gov/pubmed/33792221
http://dx.doi.org/10.3324/haematol.2020.276402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327729/
https://www.ncbi.nlm.nih.gov/pubmed/33792221
http://dx.doi.org/10.3324/haematol.2020.276402

Ejemplares similares